KEGG   DRUG: Lansoprazole, amoxicillin hydrate and metronidazole
Entry
D09742            Mixture   Drug                                   
Name
Lansoprazole, amoxicillin hydrate and metronidazole;
Lampion (TN)
Component
Lansoprazole [DR:D00355], (Amoxicillin hydrate [DR:D00229] | Amoxicillin [DR:D07452]), Metronidazole [DR:D00409]
Class
Metabolizing enzyme substrate
 DG01639  CYP2C19 substrate
 DG01633  CYP3A/CYP3A4 substrate
  DG02913  CYP3A4 substrate
Remark
ATC code: A02BD03 J01RA01
Efficacy
Antibacterial
Comment
Lansoprazole is primarily metabolized by CYP2C19 and CYP3A4.
Metabolism
Enzyme: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A02 DRUGS FOR ACID RELATED DISORDERS
   A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
    A02BD Combinations for eradication of Helicobacter pylori
     A02BD03 Lansoprazole, amoxicillin and metronidazole
      D09742  Lansoprazole, amoxicillin hydrate and metronidazole
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J01 ANTIBACTERIALS FOR SYSTEMIC USE
   J01R COMBINATIONS OF ANTIBACTERIALS
    J01RA Combinations of antibacterials
     J01RA01 Penicillins, combinations with other antibacterials
      D09742  Lansoprazole, amoxicillin hydrate and metronidazole
Drug groups [BR:br08330]
 Metabolizing enzyme substrate
  DG01639  CYP2C19 substrate
   D09742  Lansoprazole, amoxicillin hydrate and metronidazole
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    D09742  Lansoprazole, amoxicillin hydrate and metronidazole
Antimicrobials [BR:br08307]
 Antibacterials
  Cell wall biosynthesis inhibitor, beta-lactam
   Combination for eradication of H. pylori
    D09742  Lansoprazole, amoxicillin hydrate and metronidazole
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D09742
Other DBs
PubChem: 124490482
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system